EMAS Roundtable: HRT safety – Individual approach to menopause (PT)

Elena Armeni,EMAS Roundtable,Fatih Durmuşoğlu,Panagiotis Anagnostis,Tommaso Simoncini
LinkedinWhatsApp

You may also like

EMAS/ESE Webinar Part 2: Menopause
EMAS/ESE Webinar Part 2: Menopause
Andrea Giannini,Antoan Stefan Sojat,Elena Armeni,Irene Lambrinoudaki,Tim Hillard
Personalized oral combined MHT and long-term effects: How to choose according to the patient’s needs (PT)
Personalized oral combined MHT and long-term effects: How to choose according to the patient’s needs (PT)
Larysa Mishchenko,Suvarna Khadilkar,Tim Hillard
Practical Aspects of MHT: Regimen, dosage, duration of treatment, and adverse events handling (PT)
Practical Aspects of MHT: Regimen, dosage, duration of treatment, and adverse events handling (PT)
Dimitrios Goulis,Nozer Sheriar,Tobie de Villiers
Menopause beyond hot flushes: How to address common symptoms in the Asian population? (PT)
Menopause beyond hot flushes: How to address common symptoms in the Asian population? (PT)
Alfred Mueck,Bohyon Yun,Qi Yu
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (EN)
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (EN)
Elena Armeni,José Vázquez,Paulina Villaseca
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (UA)
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (UA)
Elena Armeni,José Vázquez,Paulina Villaseca
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (RU)
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (RU)
Elena Armeni,José Vázquez,Paulina Villaseca
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (ES)
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (ES)
Elena Armeni,José Vázquez,Paulina Villaseca
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (CN)
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (CN)
Elena Armeni,José Vázquez,Paulina Villaseca
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (PT)
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (PT)
Elena Armeni,José Vázquez,Paulina Villaseca
See all Webinars

European Menopause and Andropause Society

Twitter Linkedin Youtube
Contact Us
Twitter Youtube
© EMAS 2024